TPH1 and ocular melanoma: Results demonstrated that TPH1 expression increased 0.33 ± 0.13-fold after OM-LV20 treatment, whereas concurrent treatment with OM-LV20 and PACAP6-38 partly reversed this increase (Fig. 6, D and E).